M&A Deal Summary |
|
---|---|
Date | 1999-08-30 |
Target | CardioThoracic Systems |
Sector | Medical Products |
Buyer(s) | Guidant |
Deal Type | Add-on Acquisition |
Deal Value | 313M USD |
Advisor(s) | Navidar Holdco LLC (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.
DEAL STATS | # |
---|---|
Overall | 2 of 4 |
Sector (Medical Products) | 1 of 3 |
Type (Add-on Acquisition) | 2 of 4 |
State (California) | 1 of 2 |
Country (United States) | 2 of 3 |
Year (1999) | 1 of 1 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
1998-08-12 |
InControl
Redmond, Washington, United States Incontrol, Inc. designs devices for the treatment of atrial arrhythmia, a common heart-rhythm disorder. |
Buy | $135M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2003-01-03 |
Everolimus Eluting/Biosensors International/
Singapore, Singapore Biosensors International, a healthcare equipment company based in Singapore developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. |
Buy | - |